EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280,769 | -19.4% | 17,804 | -0.6% | 0.01% | -15.4% |
| Q2 2023 | $348,248 | -17.0% | 17,914 | +21.1% | 0.01% | -23.5% |
| Q1 2023 | $419,734 | -2.0% | 14,795 | +1.0% | 0.02% | -5.6% |
| Q4 2022 | $428,278 | -11.3% | 14,652 | -19.8% | 0.02% | -14.3% |
| Q3 2022 | $483,000 | -40.8% | 18,270 | -0.6% | 0.02% | -38.2% |
| Q2 2022 | $816,000 | +39.5% | 18,376 | +55.4% | 0.03% | +36.0% |
| Q1 2022 | $585,000 | -2.8% | 11,823 | 0.0% | 0.02% | +13.6% |
| Q4 2021 | $602,000 | -32.0% | 11,823 | -25.5% | 0.02% | -31.2% |
| Q3 2021 | $885,000 | +26.1% | 15,866 | -3.2% | 0.03% | +39.1% |
| Q2 2021 | $702,000 | – | 16,396 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |